Entrada Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.80

+0.16 (+2.41%)

As of Sep 22, 3:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +165.3% upside

Low Target $12.20

Average Target $18.04

High Target $27.27

Current Price $6.80

Current
$6.80

Target
$18.04

$12.20 $18.04 avg $27.27

Scenario Analysis

Bear Case

$12.20

79.4%

Low target

Base Case

$18.04

+165.3%

Avg target

Bull Case

$27.27

+301.0%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$16.45

-58.7% from high

52-Week Low

$5.02

+35.5% from low

Target vs 52W High

$18.04

+9.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%